Detalhe da pesquisa
1.
Implementation of a myasthenia gravis drug-disease interaction clinical decision support tool reduces prescribing of high-risk medications.
Muscle Nerve
; 67(4): 284-290, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36691226
2.
Consider Myocarditis When Patients Treated with Immune Checkpoint Inhibitors Present with Ocular Symptoms.
Oncologist
; 27(5): e402-e405, 2022 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348772
3.
Safety and outcomes of eculizumab for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice.
Muscle Nerve
; 66(3): 348-353, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35684980
4.
The neuromuscular fellowship portal and match.
Muscle Nerve
; 65(6): 640-645, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213933
5.
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018.
Oncologist
; 26(6): 514-522, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655682
6.
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.
Ann Neurol
; 87(5): 659-669, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32086972
7.
Retrospective analysis of safety and outcomes of rituximab for myasthenia gravis in patients ≥65 years old.
Muscle Nerve
; 64(6): 651-656, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378210
8.
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE).
Muscle Nerve
; 64(3): 270-276, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33959997
9.
COVID-19 in patients with myasthenia gravis.
Muscle Nerve
; 62(2): 254-258, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32392389
10.
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature.
Oncologist
; 24(4): 435-443, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30482825
11.
Case 22-2019: A 65-Year-Old Woman with Myopathy. Reply.
N Engl J Med
; 381(17): 1694, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31644864
12.
Case 12-2019: A 60-Year-Old Man with Weakness and Difficulty Chewing.
N Engl J Med
; 380(16): 1566-1574, 2019 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995378
13.
Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia.
N Engl J Med
; 381(3): 275-283, 2019 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31314973
14.
Neuromuscular Disorders in Pregnancy.
Semin Neurol
; 37(6): 643-652, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29270937
15.
Dual hereditary and immune-mediated neuromuscular diagnoses after cancer immunotherapy.
Muscle Nerve
; 63(3): E21-E24, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314145
16.
Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy.
Oncologist
; 25(3): e398-e404, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162817
17.
Comment on COVID-19 in patients with myasthenia gravis: Author response.
Muscle Nerve
; 62(6): E87-E88, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32954519
18.
Eculizumab: A Complementary addition to existing long-term therapies for myasthenia gravis.
Muscle Nerve
; 60(1): 7-9, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31074870
19.
Rituximab desensitization in two patients with muscle-specific kinase myasthenia gravis.
Muscle Nerve
; 60(5): E35-E37, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469920
20.
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes.
Lancet Neurol
; 23(1): 81-94, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101905